Active Transdermal Drug Delivery Device Market Report

Global and Region Active Transdermal Drug Delivery Device Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：145
  • REPORT CODE：GMM941027
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Active Transdermal Drug Delivery Device market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Active Transdermal Drug Delivery Devicemarket, defines the market attractiveness level of Active Transdermal Drug Delivery Device market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Active Transdermal Drug Delivery Device industry, describes the types of Active Transdermal Drug Delivery Device market, the applications of major players and the market size, and deeply analyzes the current situation of the global Active Transdermal Drug Delivery Device market and the development prospects and opportunities of Active Transdermal Drug Delivery Device industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Active Transdermal Drug Delivery Device market in Chapter 13.

    By Player:

    • Noven Pharmaceuticals, Inc

    • Johnson & Johnson (Janssen Pharmaceuticals Inc)

    • Echo Therapeutics, Inc

    • Mylan NV

    • Novartis AG

    • Boehringer Ingelheim GmbH

    • GlaxoSmithKline plc

    • Bayer AG

    • Actavis, Inc

    • Transdermal Corp

    • Corium International, Inc

    • 3M

    By Type:

    • Patches

    • Gels

    By End-User:

    • Clinic

    • Hospital

    • Home Use

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Active Transdermal Drug Delivery Device Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Active Transdermal Drug Delivery Device Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Active Transdermal Drug Delivery Device Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Active Transdermal Drug Delivery Device Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Active Transdermal Drug Delivery Device Market Analysis and Outlook to 2022

    • 7.1 Global Active Transdermal Drug Delivery Device Consumption (2017-2022)

    • 7.2 United States Active Transdermal Drug Delivery Device Consumption (2017-2022)

    • 7.3 Europe Active Transdermal Drug Delivery Device Consumption (2017-2022)

    • 7.4 China Active Transdermal Drug Delivery Device Consumption (2017-2022)

    • 7.5 Japan Active Transdermal Drug Delivery Device Consumption (2017-2022)

    • 7.6 India Active Transdermal Drug Delivery Device Consumption (2017-2022)

    • 7.7 South Korea Active Transdermal Drug Delivery Device Consumption (2017-2022)

    8 Region and Country-wise Active Transdermal Drug Delivery Device Market Analysis and Outlook to 2028

    • 8.1 Global Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)

    • 8.2 United States Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)

    • 8.3 Europe Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)

    • 8.4 China Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)

    • 8.5 Japan Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)

    • 8.6 India Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)

    • 8.7 South Korea Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)

    9 Global Active Transdermal Drug Delivery Device Market Outlook by Types and Applications to 2022

    • 9.1 Global Active Transdermal Drug Delivery Device Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Patches Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Gels Consumption and Growth Rate (2017-2022)

    • 9.2 Global Active Transdermal Drug Delivery Device Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Home Use Consumption and Growth Rate (2017-2022)

    10 Global Active Transdermal Drug Delivery Device Market Outlook by Types and Applications to 2028

    • 10.1 Global Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Patches Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Gels Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Home Use Consumption Forecast and Growth Rate (2022-2028)

    11 Global Active Transdermal Drug Delivery Device Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Active Transdermal Drug Delivery Device Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Active Transdermal Drug Delivery Device Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Active Transdermal Drug Delivery Device Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Active Transdermal Drug Delivery Device Market Competitive Analysis

    • 14.1 Noven Pharmaceuticals, Inc

      • 14.1.1 Noven Pharmaceuticals, Inc Company Details

      • 14.1.2 Noven Pharmaceuticals, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Noven Pharmaceuticals, Inc Active Transdermal Drug Delivery Device Product and Service

    • 14.2 Johnson & Johnson (Janssen Pharmaceuticals Inc)

      • 14.2.1 Johnson & Johnson (Janssen Pharmaceuticals Inc) Company Details

      • 14.2.2 Johnson & Johnson (Janssen Pharmaceuticals Inc) Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Johnson & Johnson (Janssen Pharmaceuticals Inc) Active Transdermal Drug Delivery Device Product and Service

    • 14.3 Echo Therapeutics, Inc

      • 14.3.1 Echo Therapeutics, Inc Company Details

      • 14.3.2 Echo Therapeutics, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Echo Therapeutics, Inc Active Transdermal Drug Delivery Device Product and Service

    • 14.4 Mylan NV

      • 14.4.1 Mylan NV Company Details

      • 14.4.2 Mylan NV Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Mylan NV Active Transdermal Drug Delivery Device Product and Service

    • 14.5 Novartis AG

      • 14.5.1 Novartis AG Company Details

      • 14.5.2 Novartis AG Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novartis AG Active Transdermal Drug Delivery Device Product and Service

    • 14.6 Boehringer Ingelheim GmbH

      • 14.6.1 Boehringer Ingelheim GmbH Company Details

      • 14.6.2 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product and Service

    • 14.7 GlaxoSmithKline plc

      • 14.7.1 GlaxoSmithKline plc Company Details

      • 14.7.2 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product and Service

    • 14.8 Bayer AG

      • 14.8.1 Bayer AG Company Details

      • 14.8.2 Bayer AG Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bayer AG Active Transdermal Drug Delivery Device Product and Service

    • 14.9 Actavis, Inc

      • 14.9.1 Actavis, Inc Company Details

      • 14.9.2 Actavis, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Actavis, Inc Active Transdermal Drug Delivery Device Product and Service

    • 14.10 Transdermal Corp

      • 14.10.1 Transdermal Corp Company Details

      • 14.10.2 Transdermal Corp Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Transdermal Corp Active Transdermal Drug Delivery Device Product and Service

    • 14.11 Corium International, Inc

      • 14.11.1 Corium International, Inc Company Details

      • 14.11.2 Corium International, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Corium International, Inc Active Transdermal Drug Delivery Device Product and Service

    • 14.12 3M

      • 14.12.1 3M Company Details

      • 14.12.2 3M Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 3M Active Transdermal Drug Delivery Device Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Active Transdermal Drug Delivery Device

    • Figure Active Transdermal Drug Delivery Device Picture

    • Table Global Active Transdermal Drug Delivery Device Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Active Transdermal Drug Delivery Device Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Active Transdermal Drug Delivery Device Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Active Transdermal Drug Delivery Device Consumption by Country (2017-2022)

    • Figure United States Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)

    • Table Europe Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)

    • Figure China Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)

    • Figure Japan Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)

    • Figure India Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)

    • Figure South Korea Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)

    • Figure Global Active Transdermal Drug Delivery Device Consumption Forecast by Country (2022-2028)

    • Figure United States Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Patches Consumption and Growth Rate (2017-2022)

    • Figure Global Gels Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Home Use Consumption and Growth Rate (2017-2022)

    • Figure Global Patches Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gels Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Home Use Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Active Transdermal Drug Delivery Device Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Active Transdermal Drug Delivery Device Export by Region (Top 5 Countries) (2017-2028)

    • Table Noven Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Noven Pharmaceuticals, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Noven Pharmaceuticals, Inc Active Transdermal Drug Delivery Device Product and Service

    • Table Johnson & Johnson (Janssen Pharmaceuticals Inc) (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Active Transdermal Drug Delivery Device Product and Service

    • Table Echo Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Echo Therapeutics, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Echo Therapeutics, Inc Active Transdermal Drug Delivery Device Product and Service

    • Table Mylan NV (Foundation Year, Company Profile and etc.)

    • Table Mylan NV Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan NV Active Transdermal Drug Delivery Device Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Active Transdermal Drug Delivery Device Product and Service

    • Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product and Service

    • Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Active Transdermal Drug Delivery Device Product and Service

    • Table Actavis, Inc (Foundation Year, Company Profile and etc.)

    • Table Actavis, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actavis, Inc Active Transdermal Drug Delivery Device Product and Service

    • Table Transdermal Corp (Foundation Year, Company Profile and etc.)

    • Table Transdermal Corp Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Transdermal Corp Active Transdermal Drug Delivery Device Product and Service

    • Table Corium International, Inc (Foundation Year, Company Profile and etc.)

    • Table Corium International, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Corium International, Inc Active Transdermal Drug Delivery Device Product and Service

    • Table 3M (Foundation Year, Company Profile and etc.)

    • Table 3M Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3M Active Transdermal Drug Delivery Device Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US